Multi-particulates offer precise control over drug release profiles, making them ideal for modified release forms. We specialize in manufacturing pellets with various release profiles (immediate, delayed, controlled, sustained, targeted, etc.), reducing dosage frequency, and minimizing side effects for enhanced patient convenience.+

Directly compressible granules are crucial in tablet manufacturing, offering a seamless transition to the final product. With our cutting-edge technology, we specialize in producing these granules, particularly with modified release profiles. Any facility can easily compress them into tablets. Our advanced technological solutions empower PFI customers to address unmet medical needs in their markets

Masking bitter tastes in oral drugs for special patient populations is a challenge. We’ve mastered taste masking without affecting drug efficacy or shelf life. Our products, including dry powders and orally disintegrating films, enhance patient compliance.

Used for solubilization of oil soluble drugs, liquids in the oil phase, and subsequently, micro emulsifying with aqueous phase containing polymer to coat over the substrate.

This method is utilized for the solubilization of oil-soluble drugs and liquids in the oil phase. Subsequently, it involves micro-emulsifying with an aqueous phase containing polymers to coat the substrate

It is used for the release of drugs with pseudo-zero kinetics and is also an alternative to OROS® technology.

This method is employed for releasing drugs through pores into an aqueous medium.